A Phase 1, Open Label, Single‑Dose, Within Cohort Randomized, 2‑Way Crossover Study To Evaluate The Pharmacokinetics Of A Modified Release Formulation Of Pf‑06650833 Under Fasting And Fed Conditions In Healthy Adult Subjects

Trial Profile

A Phase 1, Open Label, Single‑Dose, Within Cohort Randomized, 2‑Way Crossover Study To Evaluate The Pharmacokinetics Of A Modified Release Formulation Of Pf‑06650833 Under Fasting And Fed Conditions In Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Mar 2016

At a glance

  • Drugs PF 6650833 (Primary)
  • Indications Lupus-like syndrome
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 07 Mar 2016 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
    • 25 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top